Next Dose After Ozempic 0.25 mg
After completing 4 weeks on Ozempic 0.25 mg, increase to 0.5 mg once weekly. 1
Standard Dosing Algorithm
The FDA-approved titration schedule for Ozempic (semaglutide) follows a structured escalation pattern 1:
- Weeks 1-4: 0.25 mg once weekly (initiation dose - not effective for glycemic control)
- Week 5 onward: 0.5 mg once weekly (first maintenance dose)
- If additional glycemic control needed after ≥4 weeks on 0.5 mg: Increase to 1 mg once weekly
- Maximum dose: 1 mg once weekly
The 0.25 mg dose is explicitly intended only for treatment initiation to minimize gastrointestinal side effects and is not therapeutically effective for diabetes control. 1
Key Implementation Points
Timing of Dose Escalation
- Move to 0.5 mg after exactly 4 weeks on 0.25 mg 2, 3
- This gradual titration significantly reduces nausea, vomiting, and other GI adverse events that occur in up to 40% of patients without proper dose escalation 3
Further Titration Considerations
If you need to escalate beyond 0.5 mg:
- Wait at least 4 weeks on 0.5 mg before considering increase to 1 mg 1
- Base the decision on glycemic control needs, not weight loss alone (for diabetes indication)
- Some patients achieve adequate response at 0.5 mg and may not require further escalation 3
Common Pitfall to Avoid
Do not keep patients on 0.25 mg beyond 4 weeks. This dose provides no therapeutic benefit for diabetes management and delays achieving glycemic control 1. The only exception would be intolerable side effects requiring dose reduction, in which case alternative therapies should be considered.
For Weight Management Indication
If using semaglutide specifically for weight management (Wegovy formulation), the titration continues beyond 1 mg:
- 0.25 mg × 4 weeks → 0.5 mg × 4 weeks → 1 mg × 4 weeks → 1.7 mg × 4 weeks → 2.4 mg maintenance 3
However, for Ozempic (diabetes indication), 1 mg weekly is the maximum approved dose 1.